The Confederation of Respiratory Critical Care Trials (CoReCCT)
Acute respiratory failure is a common, life-threating condition associated with significant morbidity and mortality. It is a common indication for intensive care admission and frequently requires invasive or non-invasive mechanical ventilatory support. In the UK, over 60,000 adults each year receive invasive ventilation in an intensive care unit (ICU). Whilst this is a life-saving intervention, patients often experience short-term consequences including worsening lung function, hospital acquired infection and death. They also experience long-term physical, psychological and social impacts on their lives. There is an urgent need to identify innovative ventilation strategies that can be implemented easily and quickly to reduce the need for intubation and the duration of mechanical ventilation.
Aims
The primary aim of the Confederation of Critical Care Trials (CoReCCT) group is to gain efficiency in the management of acute respiratory failure trials co-enrolling in the same or similar patient populations. The primary aim of the clinical trials (domains) outlined in the CoReCCT master protocol, is to test the clinical and cost effectiveness of interventional strategies on patient outcomes in hospitalised adults with moderate-severe acute respiratory failure that require oxygen support or tracheal intubation and invasive mechanical ventilation.
The four trials within CoReCCT are:
- Neurally Adjusted Ventilatory Assist (NAVA) compared to conventional ventilation for patients at risk of difficult or prolonged weaning from invasive mechanical ventilation: The UK NAVA Trial
- Airway Pressure Release Ventilation (APRV) vs conventional ventilation for patients with moderate to severe acute hypoxemic respiratory failure: The RELEASE trial
- Awake Prone: prone positioning in awake patients without COVID-19
- PROTECT Airways: Venner Pneux™ endotracheal tube with subglottic drainage
Principal Investigators
Investigators
Affiliations
Project websites
Funding
Funding Body: National Institute for Health and Care Research
Amount: .
Period: January 2024 - December 2027
Contact us
Professor Louise Rose is a Co-Investigator and Process Evaluation Lead.